| abstract |
Novel antigenic polypeptides, including tumor-associated peptides, and compositions comprising the same are provided. Such antigenic polypeptides and compositions are particularly useful as immunotherapies (eg, cancer vaccines). Also, methods of using the polypeptides and compositions to elicit a cellular immune response, methods of treating disease using the polypeptides and compositions, kits containing the polypeptides and compositions, compositions of the invention are also provided, as well as antibodies and T-cell receptors that specifically bind to this polypeptide. |